GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: LY-3303560 | LY3303560
Compound class:
Antibody
Comment: LY3303560 is a monoclonal antibody that selectively targets tau protein aggregates [1]. It is being developed by Eli Lilly for potential to treat Alzheimer's disease. The primary epitope for LY3303560 is located in the N-terminal region of tau.
|
Classification ![]() |
|
| Compound class | Antibody |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 11050 | zagotenemab |
Synonyms ![]() |
| LY-3303560 | LY3303560 |
Database Links ![]() |
|
| GtoPdb PubChem SID | 385612231 |
| Search PubMed clinical trials | zagotenemab |
| Search PubMed titles | zagotenemab |
| Search PubMed titles/abstracts | zagotenemab |